(PWRM, FLS, IBM, WXS) Stock in Action by DrStockPick.com
Monday, March 21st, 2011
Power 3 Medical Products Inc. (PWRM)
Parkinson’s disease is a chronic neurodegenerative disease, the second most prevalent such disorder after Alzheimer’s disease. It is a slowly progressive disease caused by the death of small clusters of cells in the midbrain that results in reduction of a critical neurotransmitter called dopamine, the chemical messenger responsible for coordinated muscle movement. While research shows that genetic factors play a significant role in one type of Parkinson’s called early-onset in which symptoms begin before the age of 50, genetic predisposition is not considered a contributing factor when symptoms develop later in life.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials.
Power3 Medical Products, Inc. is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
Breast Cancer, Chemotherapeutic Drug Resistance, Alzheimer’s disease, Leukemia, ALS (Lou Gehrig’s Disease), Gastrointestinal Disease, Parkinson’s Disease and Metabolic Syndrome.
To delve into additional information about Power3 Medical Products, Inc. visit its website http://www.power3medical.com
*****************************************************************************
Flowserve Corp. (NYSE:FLS) announced an order to supply process pumps to be used in the carbon dioxide (CO2) capture process at Mississippi Power’s Kemper County integrated gasification combined cycle (IGCC) power station project. Flowserve ISO 13709/API 610 process pumps will be used in the facility’s CO2 capture unit. The Kemper County IGCC power plant is designed to capture approximately 65 percent of the CO2 emissions that would normally be released to the atmosphere. The CO2 will then be sold for use in enhanced oil recovery (EOR) operations. One of the first commercial projects in the United States to employ carbon capture at a power plant, the facility is an important milestone for low-carbon electricity production.
Flowserve Corporation develops, manufactures, and sells precision-engineered flow control equipment, as well as provides a range of aftermarket equipment services.
*******************************************
International Business Machines Corp. (NYSE:IBM) opened the first IBM Innovation Center in Mexico. Local start-ups, venture capitalists, developers and academics gathered there to begin building new skills that will drive innovation across industries such as banking, communications, healthcare, retail and government. The Mexico center joins a worldwide network of 39 IBM Innovation Centers in 32 countries - including other growth nations, such as Brazil, Vietnam, Philippines and South Africa, which have opened centers over the past two years.
International Business Machines Corporation (IBM) provides information technology (IT) products and services worldwide.
*******************************************
Wright Express Corp. (NYSE:WXS) announced the release of its new Fuel Site Locator mobile application. This latest Smartphone technology allows Wright Express customers the ability to locate the type of fuel they need at the lowest price - no matter where they are. Based on the 1+ million transactions per day that go through its proprietary network, the fuel price information that Wright Express is able to provide its customers with through this application is the most current and accurate available.
Wright Express Corporation, together with its subsidiaries, provides payment processing and information management products and services to the commercial and government vehicle fleet industry in the United States, Canada, New Zealand, Australia, and Europe.
**************************************************************
**************************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).





Power 3 Medical Products Inc. (PWRM)
American Video Teleconferencing Corp. (AVOT)
National Health Partners, Inc. (NHPR)







